| 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the … V Regitz-Zagrosek, JW Roos-Hesselink, J Bauersachs, ... European heart journal 39 (34), 3165-3241, 2018 | 3785 | 2018 |
| Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the … K Sliwa, D Hilfiker-Kleiner, MC Petrie, A Mebazaa, B Pieske, E Buchmann, ... European journal of heart failure 12 (8), 767-778, 2010 | 1250 | 2010 |
| A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy D Hilfiker-Kleiner, K Kaminski, E Podewski, T Bonda, A Schaefer, K Sliwa, ... Cell 128 (3), 589-600, 2007 | 1005 | 2007 |
| Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability B Schieffer, E Schieffer, D Hilfiker-Kleiner, A Hilfiker, PT Kovanen, ... Circulation 101 (12), 1372-1378, 2000 | 968 | 2000 |
| Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial … U Landmesser, N Engberding, FH Bahlmann, A Schaefer, A Wiencke, ... Circulation 110 (14), 1933-1939, 2004 | 606 | 2004 |
| Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study K Sliwa, L Blauwet, K Tibazarwa, E Libhaber, JP Smedema, A Becker, ... Circulation 121 (13), 1465-1473, 2010 | 605 | 2010 |
| Cardiac angiogenic imbalance leads to peripartum cardiomyopathy IS Patten, S Rana, S Shahul, GC Rowe, C Jang, L Liu, MR Hacker, ... Nature 485 (7398), 333-338, 2012 | 586 | 2012 |
| MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy J Halkein, SP Tabruyn, M Ricke-Hoch, A Haghikia, M Scherr, ... The Journal of clinical investigation 123 (5), 2143-2154, 2013 | 545 | 2013 |
| Sex differences in heart failure CSP Lam, C Arnott, AL Beale, C Chandramouli, D Hilfiker-Kleiner, ... European heart journal 40 (47), 3859-3868c, 2019 | 535 | 2019 |
| mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila A Hilfiker, D Hilfiker‐Kleiner, A Pannuti, JC Lucchesi The EMBO journal, 1997 | 526 | 1997 |
| Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology T Eschenhagen, T Force, MS Ewer, GW De Keulenaer, TM Suter, ... European journal of heart failure 13 (1), 1-10, 2011 | 500 | 2011 |
| Shared genetic predisposition in peripartum and dilated cardiomyopathies JS Ware, J Li, E Mazaika, CM Yasso, T DeSouza, TP Cappola, EJ Tsai, ... New England Journal of Medicine 374 (3), 233-241, 2016 | 466 | 2016 |
| Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion K Boengler, D Hilfiker-Kleiner, G Heusch, R Schulz Basic research in cardiology 105, 771-785, 2010 | 453 | 2010 |
| Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury D Hilfiker-Kleiner, A Hilfiker, M Fuchs, K Kaminski, A Schaefer, B Schieffer, ... Circulation research 95 (2), 187-195, 2004 | 451 | 2004 |
| Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society … S Heymans, E Hirsch, SD Anker, P Aukrust, JL Balligand, ... European journal of heart failure 11 (2), 119-129, 2009 | 431 | 2009 |
| The myocardial JAK/STAT pathway: from protection to failure K Boengler, D Hilfiker-Kleiner, H Drexler, G Heusch, R Schulz Pharmacology & therapeutics 120 (2), 172-185, 2008 | 423 | 2008 |
| Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis B Schieffer, T Selle, A Hilfiker, D Hilfiker-Kleiner, K Grote, UJF Tietge, ... Circulation 110 (22), 3493-3500, 2004 | 419 | 2004 |
| Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis P Fischer, D Hilfiker-Kleiner Basic research in cardiology 102, 393-411, 2007 | 397 | 2007 |
| Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients K Sliwa, O Förster, E Libhaber, JD Fett, JB Sundstrom, D Hilfiker-Kleiner, ... European heart journal 27 (4), 441-446, 2006 | 394 | 2006 |
| Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice K Boengler, A Buechert, Y Heinen, C Roeskes, D Hilfiker-Kleiner, ... Circulation research 102 (1), 131-135, 2008 | 366 | 2008 |
